Epigenetic alterations to Polycomb targets precede malignant transition in a mouse model of breast cancer

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Malignant breast cancer remains a major health threat to women of all ages worldwide and epigenetic variations on DNA methylation have been widely reported in cancers of different types. We profiled DNA methylation with ERRBS (Enhanced Reduced Representation Bisulfite Sequencing) across four main stages of tumor progression in the MMTV-PyMT mouse model (hyperplasia, adenoma/mammary intraepithelial neoplasia, early carcinoma and late carcinoma), during which malignant transition occurs. We identified a large number of differentially methylated cytosines (DMCs) in tumors relative to age-matched normal mammary glands from FVB mice. Despite similarities, the methylation differences of the premalignant stages were distinct from the malignant ones. Many differentially methylated loci were preserved from the first to the last stage throughout tumor progression. Genes affected by methylation gains were enriched in Polycomb repressive complex 2 (PRC2) targets, which may present biomarkers for early diagnosis and targets for treatment.

Original languageEnglish (US)
Article number5535
JournalScientific Reports
Volume8
Issue number1
DOIs
StatePublished - Dec 1 2018

Fingerprint

Epigenomics
Breast Neoplasms
DNA Methylation
Neoplasms
Methylation
Polycomb Repressive Complex 2
Carcinoma
Cytosine
Human Mammary Glands
Adenoma
Hyperplasia
Early Diagnosis
Breast
Biomarkers
Health
Genes
Therapeutics

ASJC Scopus subject areas

  • General

Cite this

@article{e43ac8f3c1974d8b814759c6e4e12904,
title = "Epigenetic alterations to Polycomb targets precede malignant transition in a mouse model of breast cancer",
abstract = "Malignant breast cancer remains a major health threat to women of all ages worldwide and epigenetic variations on DNA methylation have been widely reported in cancers of different types. We profiled DNA methylation with ERRBS (Enhanced Reduced Representation Bisulfite Sequencing) across four main stages of tumor progression in the MMTV-PyMT mouse model (hyperplasia, adenoma/mammary intraepithelial neoplasia, early carcinoma and late carcinoma), during which malignant transition occurs. We identified a large number of differentially methylated cytosines (DMCs) in tumors relative to age-matched normal mammary glands from FVB mice. Despite similarities, the methylation differences of the premalignant stages were distinct from the malignant ones. Many differentially methylated loci were preserved from the first to the last stage throughout tumor progression. Genes affected by methylation gains were enriched in Polycomb repressive complex 2 (PRC2) targets, which may present biomarkers for early diagnosis and targets for treatment.",
author = "Ying Cai and Lin, {Jhih Rong} and Quanwei Zhang and Kelly O'Brien and Cristina Montagna and Zhang, {Zhengdong D.}",
year = "2018",
month = "12",
day = "1",
doi = "10.1038/s41598-018-24005-x",
language = "English (US)",
volume = "8",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Epigenetic alterations to Polycomb targets precede malignant transition in a mouse model of breast cancer

AU - Cai, Ying

AU - Lin, Jhih Rong

AU - Zhang, Quanwei

AU - O'Brien, Kelly

AU - Montagna, Cristina

AU - Zhang, Zhengdong D.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Malignant breast cancer remains a major health threat to women of all ages worldwide and epigenetic variations on DNA methylation have been widely reported in cancers of different types. We profiled DNA methylation with ERRBS (Enhanced Reduced Representation Bisulfite Sequencing) across four main stages of tumor progression in the MMTV-PyMT mouse model (hyperplasia, adenoma/mammary intraepithelial neoplasia, early carcinoma and late carcinoma), during which malignant transition occurs. We identified a large number of differentially methylated cytosines (DMCs) in tumors relative to age-matched normal mammary glands from FVB mice. Despite similarities, the methylation differences of the premalignant stages were distinct from the malignant ones. Many differentially methylated loci were preserved from the first to the last stage throughout tumor progression. Genes affected by methylation gains were enriched in Polycomb repressive complex 2 (PRC2) targets, which may present biomarkers for early diagnosis and targets for treatment.

AB - Malignant breast cancer remains a major health threat to women of all ages worldwide and epigenetic variations on DNA methylation have been widely reported in cancers of different types. We profiled DNA methylation with ERRBS (Enhanced Reduced Representation Bisulfite Sequencing) across four main stages of tumor progression in the MMTV-PyMT mouse model (hyperplasia, adenoma/mammary intraepithelial neoplasia, early carcinoma and late carcinoma), during which malignant transition occurs. We identified a large number of differentially methylated cytosines (DMCs) in tumors relative to age-matched normal mammary glands from FVB mice. Despite similarities, the methylation differences of the premalignant stages were distinct from the malignant ones. Many differentially methylated loci were preserved from the first to the last stage throughout tumor progression. Genes affected by methylation gains were enriched in Polycomb repressive complex 2 (PRC2) targets, which may present biomarkers for early diagnosis and targets for treatment.

UR - http://www.scopus.com/inward/record.url?scp=85044974578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044974578&partnerID=8YFLogxK

U2 - 10.1038/s41598-018-24005-x

DO - 10.1038/s41598-018-24005-x

M3 - Article

C2 - 29615825

AN - SCOPUS:85044974578

VL - 8

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 5535

ER -